Pink SheetA US Centers for Disease Control and Prevention panel’s divided endorsement of Merck & Co .’s Enflonsia (clesrovimab-cfor) for prevention of respiratory syncytial virus in infants suggests that p
Pink SheetThe first meeting of the reconstituted US Centers for Disease Control and Prevention vaccine advisory committee began with the new chairman comparing vaccines to airplanes and vowing to use evidence-b
Pink SheetMichael Davis, the Center for Drug Evaluation and Research’s new deputy director, brings experience leading US Food and Drug Administration reviews and psychedelic drug development. CDER Acting Direct
Pink SheetSome private US insurers may avoid covering new vaccines without an official endorsement from the US Centers for Disease Control and Prevention’s reconstituted Advisory Committee on Immunization Pract